BackRevance Therapeutics Overview

Revance Therapeutics Cost of Revenue

Cost of Revenue analysis for RVNC.

Quarterly Cost of Revenue

$17.63M
↓ 9.17% YoY

As of Sep 30, 2024

Annual Cost of Revenue (TTM)

$72.48M
↓ 9.86% YoY

Trailing 12 months ending Sep 30, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin